Bharat Tewarie

Bharat has led Helio Genomics as CEO since July 2025, driving the company's mission to make earlier cancer detection a clinical reality. He brings decades of global healthcare leadership across the US and Europe, including roles such as Executive Vice President and Chief Marketing Officer at UCB. With both an MD and an MBA, he combines clinical insight with commercial strategy to guide Helio's growth and the advancement of HelioLiver LDT.